Genetics and measles, mumps and rubella vaccine response in childhood and adolescence—A systematic review

Marie Mykløy Haslund, Jesper Kiehn Sørensen, Lone Graff Stensballe*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftReviewpeer review

5 Citationer (Scopus)
12 Downloads (Pure)

Abstract

Measles, mumps and rubella (MMR) are contagious infectious diseases that can be prevented by immunization. However, MMR infections can occur in previously immunized individuals. The vaccine response is, among other factors, influenced by the combined effects of many genes. This systematic review investigates the genetic influence on measles, mumps and rubella antibody responses after childhood vaccination. In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), systematic literature searches were conducted in the medical databases PubMed, EMBASE and PsycINFO. Search strings were adjusted for each database. Citations were included if they measured and compared the immune response with immunogenetics after vaccination with a vaccine containing one or more of the following components: measles, mumps and/or rubella, MMR. The measure of vaccine response studied was antibodies after vaccination. Forty-eight articles were included in the final analysis. The results suggest that genetic determinants, including host genes, and single nucleotide polymorphisms in immune-related genes influence the MMR antibody responses after vaccination. Specifically, replicated associations were found between HLA, CD46, RARB, IRF9, EIF2AK2, cytokine genes and MMR vaccine-induced humoral immune responses. This knowledge can be useful in understanding and predicting immune responses and may have implications for future vaccine strategies.

OriginalsprogEngelsk
Artikelnummere13266
TidsskriftScandinavian Journal of Immunology
Vol/bind97
Udgave nummer6
ISSN0300-9475
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This review is written by members of the 6 months MMR study at The Danish National University Hospital, Rigshospitalet. The study is funded by the hospital and the innovation fund Denmark. All authors attest that they meet the ICMJE criteria for authorship. There are no conflicts of interest. 72

Publisher Copyright:
© 2023 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology.

Citationsformater